Prevention of coronary heart disease in clinical practice: Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention1European Society of Cardiology, European Atherosclerosis Society, European Society of Hypertension, International Society of Behavioural Medicine, European Society of General Practice/Family Medicine, European Heart Network.1,2Published simultaneously in the European Heart Journal 1998;19:1434–1503 and the Journal of Hypertension (Summary only) 1998;16(10).2
Generate an AI Snapshot to get a quick, structured summary of this paper.
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
The Task Force has summarized the most important clinical issues on coronary heart disease prevention on which there is good agreement in order to give cardiologists and physicians, and other health care professionals, the best possible advice to facilitate their work on coronaryHeart disease prevention.
Abstract
Since the first Joint European Societies—European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension—Task Force recommendations on coronary heart disease prevention in clinical practice were published in 1994 new scientific evidence has emerged in both secondary and primary coronary prevention, particularly in relation to lipid lowering. Therefore, a second Task Force was convened by the three major societies, including professional representatives from behavioural medicine, primary care and the European Heart Network, to revise the recommendations.
